Psychotropic Drug Directory supports the optimal and rational use of medicines, to improve the quality of life for people with mental health needs.
Close
Close
Contact our team to see how our services can directly help you.
Close
Access our useful resources today to help your organisation realise the benefits of subscribing to Psychotropic Drug Directory through MedicinesComplete. Including patient case studies covering everyday clinical scenarios, and an on-demand webinar showing how to navigate independent information, advice, and commentary on psychotropic drugs.
Close
Register for this webinar to learn how MedicinesComplete can support you in implementing effective processes to reduce medication errors and improve patient safety.
Close
Learn more about adverse drug reactions in our article.
Close
As the Royal Pharmaceutical Society’s knowledge business, Pharmaceutical Press supports health professionals across the world with evidence-based pharmaceutical knowledge to improve patient safety. And as a not-for-profit organisation, we invest all our resources into creating trusted products and workflow tools that promote best practice in medicines use.
Find out how our services and knowledge products help your sector
We also license our content to customers including EMR and healthcare application vendors.
The latest and most relevant medicines information, curated by our experienced editorial team of clinical and scientific writers – available at your finger tips 24/7.
Our knowledge products are regularly updated online through MedicinesComplete
14th January 2025
We have released some changes to how Pharmaceutical Excipients content…
14th January 2025
Pharmaceutical ExcipientsWe have released some changes to how Pharmaceutical Excipients content is displayed on MedicinesComplete to improve your user experience. For more information, see our FAQs here: https://www.pharmaceuticalpress.com/pharmaceutical-excipients-faqs/
This update also contains 1 new monograph (inositol).
14th January 2025
This update contains revisions to Niacin, Pantothenic acid, Riboflavin, and…
14th January 2025
Dietary SupplementsThis update contains revisions to Niacin, Pantothenic acid, Riboflavin, and Vitamin B12.
14th January 2025
For January, 1 new medicine has been added, and numerous…
14th January 2025
Electronic Medicines Compendium (emc)For January, 1 new medicine has been added, and numerous medicines have been amended.
14th January 2025
This update contains 15 significant changes, 4 dose changes, 4…
14th January 2025
British National FormularyThis update contains 15 significant changes, 4 dose changes, 4 new monographs, 3 new preparations and 3 deleted monographs.
Significant Changes:
Cefotaxime: removal of indication and dose for emergency treatment of suspected bacterial meningitis or meningococcal disease, before urgent transfer to hospital, in patients who cannot be given benzylpenicillin.
Ceftriaxone: update to indications and dosing for pre-hospital treatment of suspected bacterial meningitis and meningococcal disease.
Central nervous system infections, antibacterial therapy: updated guidance on management.
Chloramphenicol: updated monitoring advice.
Dexamethasone: update to dose advice for adjunctive treatment of suspected bacterial meningitis.
Diabetic foot infections, antibacterial therapy: updated guidance on fluoroquinolones.
Gastro-intestinal system infections, antibacterial therapy: updated guidance on fluoroquinolones.
Glatiramer acetate: anaphylactic reactions may occur months to years after treatment initiation [MHRA/CHM advice].
GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse [MHRA/CHM advice] (advice in dulaglutide, exenatide, liraglutide, lixisenatide, semaglutide and tirzepatide; see example in liraglutide).
Mavacamten: pre-treatment screening advice on genetic testing for treating symptomatic obstructive hypertrophic cardiomyopathy.
Medical emergencies in the community: update to antibacterials for suspected bacterial meningitis and meningococcal disease.
Medroxyprogesterone acetate: risk of meningioma and measures to minimise this risk [MHRA/CHM advice].
Respiratory system infections, antibacterial therapy: updated guidance on fluoroquinolones.
Urinary-tract infections: updated guidance on fluoroquinolones.
Urinary-tract infections: updated guidance on treatment of lower urinary-tract infections.
Dose Changes:
Cefotaxime [removal of intramuscular route for severe susceptible infections due to sensitive Gram-positive and Gram-negative bacteria, and meningitis].
Ceftriaxone [removal of intramuscular route for meningitis].
Ceftriaxone [update to indications and dosing for meningitis and meningococcal disease].
Fluconazole [update to indications and dosing].
New Monographs:
Iqirvo® [elafibranor].
Piasky® [crovalimab].
Sogroya® [somapacitan].
Voydeya® [danicopan].
New Preparations: Alutard SQ Bee® [bee venom extract]; Alutard SQ Wasp® [wasp venom extract]; Itulazax 12 SQ-Bet® [tree pollen extract].
Deleted Monographs: Belantamab mafodotin; Crizanlizumab; Voxelotor.
14th January 2025
One record has been selectively revised. Pharmacopoeial information has also been updated….
14th January 2025
Herbal MedicinesOne record has been selectively revised. Pharmacopoeial information has also been updated.
Selective revision: Ginger.
Minor updates: British Pharmacopoeia, European Pharmacopoeia, and USP-NF information have been globally updated.
14th January 2025
This update contains 13 significant changes, 4 dose changes, 2…
14th January 2025
BNF for ChildrenThis update contains 13 significant changes, 4 dose changes, 2 new monographs, 2 new preparations and 2 deleted monographs.
Significant Changes:
Cefotaxime: removal of indication and dose for emergency treatment of suspected bacterial meningitis or meningococcal disease, before urgent transfer to hospital, in patients who cannot be given benzylpenicillin.
Ceftriaxone: update to indications and dosing for pre-hospital treatment of suspected bacterial meningitis and meningococcal disease.
Central nervous system infections, antibacterial therapy: updated guidance on management.
Chloramphenicol: updated monitoring advice.
Dexamethasone: update to dose advice for adjunctive treatment of suspected bacterial meningitis.
Fever: updated guidance on management.
GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse [MHRA/CHM advice] (advice in dulaglutide, liraglutide and semaglutide; see example in liraglutide).
Medical emergencies in the community: update to antibacterials for suspected bacterial meningitis and meningococcal disease.
Medroxyprogesterone acetate: risk of meningioma and measures to minimise this risk [MHRA/CHM advice].
Neonatal infection, antibacterial therapy: updated guidance on management.
Respiratory system infections, antibacterial therapy: updated guidance on fluoroquinolones.
Urinary-tract infections: updated guidance on fluoroquinolones.
Urinary-tract infections: updated guidance on treatment of lower urinary-tract infections.
Dose Changes:
Cefotaxime [removal of intramuscular route for severe susceptible infections due to sensitive Gram-positive and Gram-negative bacteria, and meningitis].
Ceftriaxone [removal of intramuscular route for meningitis].
Ceftriaxone [update to indications and dosing for meningitis and meningococcal disease].
Fluconazole [update to indications and dosing].
New Monographs:
Piasky® [crovalimab].
Sogroya® [somapacitan].
New Preparations: Alutard SQ Bee® [bee venom extract]; Alutard SQ Wasp® [wasp venom extract].
Deleted Monographs: Crizanlizumab; Voxelotor.
New, Psychotropic Drug Directory supports the optimal and rational use of medicines, to improve the quality of life for people with mental health needs.
“Martindale: The Complete Drug Reference helps me provide clinicians and consumers with comprehensive responses to their medicine enquiries.”
Marijana Putnikovic, Senior Pharmacist, Medicines Information, SA Health, Australia
“MedicinesComplete is essential to support the day-to-day practice of not only pharmacists and medicines information staff, but a wide-range of health professionals.”
Derek Boyle, Senior Knowledge Manager, Knowledge Management & Discovery Unit, NHS Education for Scotland (NES), UK
“Information we seek is instantly available at our fingertips. MedicinesComplete search queries lead to a broad range of results across all the publications we subscribe to.”
Sheila O’Loughlin, Supervising Pharmacist, Killan’s CarePlus Pharmacy, Ireland
Want to know how we can help you? Learn more about our services.
Find out how we can support your organisation, contact us now for pricing and access information.
Independent and with a rigorous, accredited content creation process, BNF and BNF for Children are trusted worldwide for evidence-based guidance on prescribing, dispensing and administering medicines.
Info
Info
Info
See all our printed publications in the Shop.
